Abstract
1,4-Dihydropyridines have been recognized as calcium channel agonist. Three new analogues of Bay K8644 in which the ortho trifluromethyl phenyl group at position 4 is replaced by the 4-(5)-Chloro-2-ethyl-5-(4)-imidazolyl substituent, were designed and synthesized as calcium channel agonist. For this propose, the structures of designed compounds were drawn by HYPERCHEM program. Conformations of the compounds were optimized through semi-empirical method followed by PM3 calculation. Then the crystalin stucture of L-type calcium channel was obtained from the Protein Data Bank (PDB) server. Docking calculations were carried out using Auto-Dock.4 program. The good interaction of our 1,4-DHP derivatives showed that they can be as possible calcium channel agonist agents. Finally compounds were synthesized according to a modified Hantzsch condensation procedure.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Davood, A., Khodarahmi, G., Alipour, E., Dehpour, A., Amini, M., and Shafiee, A., Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4(5)-chloro-2-methyl-5(4)-imidazolyl substituent. Boll. Chim. Farm., 140, 381–386., (2001).
Davood, A., Mansouri, N., Dehpour, A., Shafaroudi, H., Alipour, E., and Shafiee, A., Design, Synthesis, and Calcium Channel Antagonist Activity of New 1,4-Dihydropyridines Containing 4-(5)-Chloro-2-ethyl-5-(4)-imidazolyl Substituent. Arch Pharm Chem Life Sci, 339, 299–304 (2006).
Doyle, D. A., Cabral, J. M., Pfuetzner, R. A., Kuo, A., Gulbis, J. M., Cohen, S. L., Chait, B. T., and MacKinnon, R., Science, 280, 69–77 (1998).
Duncan, B. Judd, Michael D. Dowle, David Middlemiss, David I. C. Scopes, Barry C. Ross, Torquil I. Jack, Martin Pass, Elvira Tranquillini, Julie E. Hobson, Bromobenzofuran-Based Non-peptide Antagonists of Angiotensin II: GR138950, a Potent Antihypertensive Agent with High Oral Bioavailability. J. Med. Chem., 37(19), 3108–3120 (1994).
Huey, R. and Morris, G. M., Using AutoDock 4 with Auto-DockTools. (2007).
Li, A. H., Moro, S., Melman, N., Ji, X. D., and Jacobson, K. A., Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J. Med. Chem., 41, 3186–3201 (1998).
Perozo, E., Cortes, D. M., and Cuello, L. G., Structural rearrangements underlying K+-channel activation gating. Science, 285, 73–78, (1999).
Rasmussen, H. and Barret, P. Q., Calcium messenger system: an integrated view. Physiol. Rev., 64, 938–984 (1984).
Weidenhagen, R. and Herrmann, R., Eine neue synthese von imidazol-derivaten. Ber. Dtsch. Chem. Ges, 68, 953–961 (1935).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Davood, A., Nematollahi, A.r., Iman, M. et al. Synthesis and docking studies of new 1,4-dihydropyridines containing 4-(5)-Chloro-2-ethyl-5-(4)-imidazolyl substituent as novel calcium channel agonist. Arch. Pharm. Res. 32, 481–487 (2009). https://doi.org/10.1007/s12272-009-1401-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-009-1401-0